TrendFlares logo

Morphic Holding, Inc. (MORF)

$56.99 0.00% $0.00 Healthcare

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

$2.86B

Dr. Praveen P. Tipirneni M.D.

103.00

Waltham, MA

Jun 27, 2019

-14.88

$-3.83

1.92

24.13

298.54%

-15.88

-1.42

4.62

-47.52

24.13

-27.83%

-26.62%

Uptrend

Similar stocks (14)

Vaxcyte, Inc.

PCVX

$117.12 0.50%
Uptrend

Revolution Medicines, Inc.

RVMD

$46.18 4.81%
Uptrend

Viking Therapeutics, Inc.

VKTX

$68.16 5.76%
Uptrend

Avidity Biosciences, Inc.

RNA

$45.65 2.29%
Uptrend

Madrigal Pharmaceuticals, Inc.

MDGL

$242.25 3.90%
Downtrend

Arcellx, Inc.

ACLX

$85.43 6.06%
Uptrend

Protagonist Therapeutics, Inc.

PTGX

$45.92 2.57%
Uptrend

Akero Therapeutics, Inc.

AKRO

$28.00 3.86%
Uptrend

89bio, Inc.

ETNB

$8.29 -0.24%
Downtrend

Stoke Therapeutics, Inc.

STOK

$15.14 -0.53%
Uptrend

Pliant Therapeutics, Inc.

PLRX

$12.62 0.96%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.78 -0.52%
Uptrend

Ventyx Biosciences, Inc.

VTYX

$2.37 3.49%
Downtrend

ETF Exposure (18)

Vanguard Health Care Fund Admiral Shares

VGHAX

0.26%

$98.38 0.65%
Uptrend

Vanguard Health Care Fund

VGHCX

0.26%

$233.27 0.66%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.17%

$150.33 1.93%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.08%

$90.58 2.07%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0383069083%

$51.96 1.90%
Uptrend

Vanguard Health Care Index Fund

VHT

0.03%

$286.45 0.57%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.03%

$138.77 2.02%
Uptrend

Vanguard Extended Market Index Fund

VXF

0.03%

$182.92 2.00%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0024744039%

$66.24 1.72%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend